Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Madison Avenue Partners, LP Stock Portfolio

$791Million– No. of Holdings #20

Madison Avenue Partners, LP Performance:
2024 Q2: -3.46%YTD: -2.95%2023: 6.71%

Performance for 2024 Q2 is -3.46%, and YTD is -2.95%, and 2023 is 6.71%.

About Madison Avenue Partners, LP and 13F Hedge Fund Stock Holdings

Madison Avenue Partners, LP is a hedge fund based in NEW YORK, NY. On 07-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.6 Billions. In it's latest 13F Holdings report, Madison Avenue Partners, LP reported an equity portfolio of $791.6 Millions as of 30 Jun, 2024.

The top stock holdings of Madison Avenue Partners, LP are GHC, , GMED. The fund has invested 20.6% of it's portfolio in GRAHAM HLDGS CO and 16.5% of portfolio in SOLVENTUM CORP.

The fund managers got completely rid off HESS CORP (HES), ORION GROUP HLDGS INC (ONL) and MERRIMACK PHARMACEUTICALS INC (MACK) stocks. They significantly reduced their stock positions in HOMESTREET INC (HMST) and SHARKNINJA INC. Madison Avenue Partners, LP opened new stock positions in SOLVENTUM CORP, QUIDELORTHO CORP (QDEL) and DUCOMMUN INC DEL (DCO). The fund showed a lot of confidence in some stocks as they added substantially to ATMUS FILTRATION TECHNOLOGIES INC, GLOBUS MED INC (GMED) and THERAVANCE BIOPHARMA INC (TBPH).
Madison Avenue Partners, LP Equity Portfolio Value
Last Reported on: 14 Aug, 2024

Madison Avenue Partners, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Madison Avenue Partners, LP made a return of -3.46% in the last quarter. In trailing 12 months, it's portfolio return was 3.48%.

New Buys

Ticker$ Bought
solventum corp130,346,000
quidelortho corp49,735,300
ducommun inc del22,207,700
news corp new11,801,100
zimvie inc4,944,420
news corp new1,491,440

New stocks bought by Madison Avenue Partners, LP

Additions

Ticker% Inc.
atmus filtration technologies inc441
globus med inc101
indivior plc37.16
theravance biopharma inc21.38
wiley john & sons inc19.3
ovid therapeutics inc11.88
graham hldgs co10.8
2seventy bio inc5.34

Additions to existing portfolio by Madison Avenue Partners, LP

Reductions

Ticker% Reduced
homestreet inc-73.38
sharkninja inc-60.07
central & eastern europe fd-20.29

Madison Avenue Partners, LP reduced stake in above stock

Sold off

Ticker$ Sold
gossamer bio inc-4,886,110
orion group hldgs inc-9,191,040
merrimack pharmaceuticals inc-5,719,250
hess corp-45,833,200

Madison Avenue Partners, LP got rid off the above stocks

Sector Distribution

Madison Avenue Partners, LP has about 29.9% of it's holdings in Healthcare sector.

Sector%
Healthcare29.9
Others25.7
Consumer Defensive20.6
Communication Services16.2
Financial Services4
Industrials2.8

Market Cap. Distribution

Madison Avenue Partners, LP has about 1.7% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP51.3
UNALLOCATED25.7
SMALL-CAP18.7
MICRO-CAP2.6
LARGE-CAP1.7

Stocks belong to which Index?

About 55.1% of the stocks held by Madison Avenue Partners, LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200053.4
Others44.9
S&P 5001.7
Top 5 Winners (%)%
GMED
globus med inc
15.8 %
ZIMV
zimvie inc
13.9 %
STGW
stagwell inc
9.7 %
WLY
wiley john & sons inc
6.8 %
NNI
nelnet inc
6.6 %
Top 5 Winners ($)$
GMED
globus med inc
13.2 M
STGW
stagwell inc
4.3 M
WLY
wiley john & sons inc
4.2 M
NNI
nelnet inc
1.8 M
NWS
news corp new
0.7 M
Top 5 Losers (%)%
OVID
ovid therapeutics inc
-74.9 %
FSP
franklin str pptys corp
-32.6 %
TSVT
2seventy bio inc
-27.4 %
HMST
homestreet inc
-26.4 %
QDEL
quidelortho corp
-20.7 %
Top 5 Losers ($)$
GHC
graham hldgs co
-14.8 M
QDEL
quidelortho corp
-13.0 M
OVID
ovid therapeutics inc
-9.3 M
TBPH
theravance biopharma inc
-4.2 M
TSVT
2seventy bio inc
-3.7 M

Madison Avenue Partners, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Madison Avenue Partners, LP

Madison Avenue Partners, LP has 20 stocks in it's portfolio. About 92.7% of the portfolio is in top 10 stocks. GHC proved to be the most loss making stock for the portfolio. GMED was the most profitable stock for Madison Avenue Partners, LP last quarter.

Last Reported on: 14 Aug, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions